Former Rexall Pharma Plus chief executive officer Frank Scorpiniti has taken the helm at the Earth Fare natural food retailer. Scorpiniti, a chain drug industry veteran who resigned from Rexall this fall, has been CEO of Earth Fare since October.
With an eye on boosting its effort to develop an integrated pharmacy experience, CVS Health has signed a lease for office space in Boston that will be home to its new Digital Innovation Lab.
A German court has given the green light to McKesson Corp. and Celesio AG to operate as an integrated company.
John Foley, who in his most recent position served as corporate vice president for eastern operations at Walgreen Co., has retired after a 29-year career with the company.
National health spending last year continued a trend of low growth, according to an analysis from the Office of the Actuary at the Centers for Medicare and Medicaid Services (CMS). The CMS Office of the Actuary estimates that in 2013 U.S. health care spending in the grew at a rate of 3.6% over
The November midterm elections, which resulted in Republicans taking control of the Senate, also saw “significant Republican gains in state legislatures,” according to an analysis of the results by the National Association of Chain Drug Stores.
Changes within the executive ranks in the chain drug industry are coming at a faster pace these days than at any time in the industry’s history.
Sweeping changes will begin to transform the pharmaceutical supply chain at the start of 2015, when the first provisions of the Drug Supply Chain Security Act take effect.
the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail. In this column, we explore the ways promotion impacts buyer and shopper behavior.
The passage of the Patient Protection and Affordable Care Act in 2010 (ACA) promised fundamental changes in the American health care environment.
Can retail pharmacies beat other players to patient intimacy? Many pharmacy retailers understand that big data can improve business operations, enabling intimate consumer engagement and thereby driving bigger baskets and more door turns, along with healthier customers and margins.
Merck & Co. said Monday it will acquire Cubist Pharmaceuticals Inc. for $8.4 billion. The transaction will include $1.1 billion in net debt (based on projected cash balances) and other considerations for a total transaction value of about $9.5 billion.
GlaxoSmithKline PLC (GSK) has reversed a plan to possibly sell some of its established drugs in order to focus on fast-growing medications.
First Quality Tissue, a manufacturer of private-label and branded paper towels and tissue, is moving forward with several capacity expansion projects.
Galderma Laboratories’ Cetaphil skin care brand has made a foray in the baby product arena with the launch of Cetaphil Baby. Making its debut this week, the line includes five products: Cetaphil Baby Diaper Cream, Wash and Shampoo, Ultra Moisturizing Wash, Daily Lotion and Moisturizing Oil.
Avanir Pharmaceuticals Inc. has entered into an agreement to be acquired by Otsuka Pharmaceutical Co. Ltd. in a deal valued at $3.5 billion.
